Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indo US Bio-Tech's yield on cost for the quarter that ended in Mar. 2026 was 0.00.
The historical rank and industry rank for Indo US Bio-Tech's 5-Year Yield-on-Cost % or its related term are showing as below:
During the past 13 years, Indo US Bio-Tech's highest Yield on Cost was 0.20. The lowest was 0.09. And the median was 0.16.
NSE:INDOUS's 5-Year Yield-on-Cost % is not ranked *
in the Agriculture industry.
Industry Median: 3.12 * Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
Indo US Bio-Tech (NSE:INDOUS) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Indo US Bio-Tech 5-Year Yield-on-Cost % Related Terms
NSE:INDOUS vs CTVA, CF, MOS: 5-Year Yield-on-Cost % Comparison
For the Agricultural Inputs subindustry, Indo US Bio-Tech's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo US Bio-Tech 5-Year Yield-on-Cost % vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Indo US Bio-Tech's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Indo US Bio-Tech's 5-Year Yield-on-Cost % falls into.
Indo US Bio-Tech 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Indo US Bio-Tech (NSE:INDOUS) has a 5-Year Yield-on-Cost % of 0.00 as of Aug. 09, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Indo US Bio-Tech and its competitors. Over the past decade, Indo US Bio-Tech's 5-Year Yield-on-Cost % has ranged from 0.09 to 0.20. According to the industry distribution chart, Indo US Bio-Tech ranks #999999 out of 145 companies in the Agriculture industry.
Is Indo US Bio-Tech's 5-Year Yield-on-Cost % too high?
Indo US Bio-Tech's current 5-Year Yield-on-Cost % is 0.00. Over the past 10 years, this metric has ranged from a low of 0.09 to a high of 0.20. Based on the distribution chart, Indo US Bio-Tech ranks #999999 out of 145 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Indo US Bio-Tech has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Indo US Bio-Tech's 5-Year Yield-on-Cost % compare to CTVA and CF?
According to the Agriculture industry distribution chart, Indo US Bio-Tech ranks #999999 out of 145 companies for 5-Year Yield-on-Cost %. This places Indo US Bio-Tech in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 3.12. Historically, Indo US Bio-Tech's own 5-Year Yield-on-Cost % has ranged from 0.09 to 0.20 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for an Agriculture company?
The median 5-Year Yield-on-Cost % among Agriculture companies is 3.12, based on 145 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Indo US Bio-Tech and its competitors. For the Agriculture industry, the median 5-Year Yield-on-Cost % is 3.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo US Bio-Tech's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo US Bio-Tech stock overvalued right now?
Based on GuruFocus' analysis, Indo US Bio-Tech (NSE:INDOUS) is currently considered Possible Value Trap. The stock's GF Value™ is ₹316.88, compared to a current price of ₹81.65 — trading 74.2% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. Indo US Bio-Tech's overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Indo US Bio-Tech (NSE:INDOUS), the current 5-Year Yield-on-Cost % is 0.00 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo US Bio-Tech (NSE:INDOUS) Overvalued in 2026?
Based on GuruFocus' analysis, Indo US Bio-Tech stock appears to be undervalued.
The current stock price of ₹81.65 is trading 74.2% below its estimated GF Value™ of ₹316.88.
GuruFocus considers Indo US Bio-Tech to be Possible Value Trap.
Key valuation signals for NSE:INDOUS:
5-Year Yield-on-Cost %: 0.00
GF Value™: ₹316.88 vs. price of ₹81.65 (74.2% below fair value)
No single metric tells the full story. See the NSE:INDOUS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo US Bio-Tech Ltd is a specialized agriculture seed company. It is involved in crop research and development through breeding, production of seeds, processing, packing, and marketing of high-performing hybrid and open-pollinated varieties of crops. The company's product portfolio includes a diversified variety of agricultural seeds, namely vegetable seeds, oil seeds, pulses seeds, cereals seeds, spices seeds used in cultivating all kinds of vegetables, pulses, crops like tomato, okra, brinjal, onion, bit root, cucumber, bottle gourd, groundnut, mustard, bajra, wheat, etc.
64GF Score
Get the complete analysis for NSE:INDOUS
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOUS has been successfully added to your 
